Physician profile
Jonathan R Moss
NPI 1447307244
$3,840.56
in general payments reported to CMS, 2019-2025
22 companies · $647 in 2025
The $647 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,143 · 2021: $457 · 2022: $634 · 2023: $568 · 2024: $392 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,607.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $864.25 | 2019-2025 | |
| Genzyme Corporation | $758.32 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $437.50 | 2022-2024 | Dupixent |
| Covidien LP | $325.00 | 2019 | |
| Acclarent, INC | $245.35 | 2019-2022 | |
| Medtronic, INC. | $243.05 | 2023-2025 | Stealthstation S8 Platform, Propel |
| Stryker Corporation | $231.94 | 2019-2022 | |
| Integra Lifesciences Corporation | $164.78 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Neurent Medical Limited | $135.25 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Medtronic USA, INC. | $110.00 | 2019 | |
| Restor3d, INC. | $104.60 | 2023 | |
| Ars Pharmaceuticals Operations, INC. | $56.11 | 2025 | Neffy |
| Intersect Ent, INC. | $39.32 | 2019-2021 | |
| Karl Storz Endoscopy-America | $26.11 | 2023 | N.A. |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $21.63 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $18.67 | 2025 | Nucala |
| Astrazeneca Pharmaceuticals LP | $18.18 | 2025 | Tezspire |
| Alk-Abello, INC | $15.18 | 2021 | |
| Kaleo, INC. | $13.57 | 2019 | |
| Aerin Medical INC. | $11.75 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.